Exane Derivatives’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $517K | Buy |
6,963
+6,000
| +623% | +$446K | 0.3% | 83 |
|
|
2022
Q1 | $86.5K | Hold |
963
| – | – | 0.02% | 489 |
|
|
2021
Q4 | $108K | Hold |
963
| – | – | 0.03% | 429 |
|
|
2021
Q3 | $121K | Buy |
963
+62
| +7% | +$7.79K | 0.03% | 489 |
|
|
2021
Q2 | $117K | Hold |
901
| – | – | 0.03% | 512 |
|
|
2021
Q1 | $122K | Hold |
901
| – | – | 0.03% | 382 |
|
|
2020
Q4 | $127K | Sell |
901
-199
| -18% | -$28K | 0.04% | 354 |
|
|
2020
Q3 | $123K | Buy |
+1,100
| New | +$123K | 0.04% | 259 |
|